Latest News

image2020-4-6_14-52-40

Unified Screening Platform (USP) for Screening COVID-19

The world is experiencing a heavy burden with the coronavirus disease pandemic (also called COVID-19 or SARS-CoV-2). Almost all countries are preventing contamination and treating patients the best they can. Currently, the main focus is on treatment, but as the pandemic develops, the need for a structured COVID-screening program is growing massively. This is because quarantining the entire population for several months or perhaps several years is not feasible: there needs to be a structured approach for un-quarantining (parts of) the population. We foresee that large population screening programs will be a piece of this complex strategic puzzle.

At this moment we are noticing an upcoming demand for national data management systems to support these large population based screening programs. Both the screening to determine whether a person is infected (for example performing a blood test, oral swab test or a CT-scan) and the screening wether a person already had the disease (using antibody tests) will be needed. With more than 25 years of experience in large scale screening programs in countries all over the world, RADventure supports you to conduct these kind of programs with our Unified Screening Platform (USP).

USP is a flexible data management software environment that provides what is needed to implement large scale screening programs. With USP, the population can be organized in target groups based on different parameters (such as the person's age, gender, living area, previous studies results, etc). Based on these parameters each individual client is invited for a specific workflow and tracked from the first contact until the end of the defined screening workflow. The planning for the screening program can be set for the whole population or incrementally, prioritizing invitations based on specific criteria. Doing so it is possible to invite clients for a specific workflow, and/or area, or invite a selected group to a specific Screening Unit or specific workflow. Regarding planning and monitoring, USP has a Central Unit that can configure, plan and monitor different Screening Units (fixed and/or mobile). Due to the modular architecture, USP is flexible and ready to be integrated in other health care environments (like Hospital Information Systems and Laboratory Information Systems).

We are happy to advise and support you on the (data) management part of COVID-19 screening programs.

ROBINSCA-MR-LOGO

ROBINSCA-MR study has started!

This month, after a long period of preparations, the ROBINSCA-MR study started. In this study, an MRI scan of the heart is performed on a subset of the ROBINSCA participants who have undergone a CT scan (Intervention Group B). In collaboration with the University Medical Center Groningen (UMCG), it is being investigated whether early indications of an imminent heart attack or sudden cardiac death can be found with this MRI scan.

Participants in the ROBINSCA study who have undergone a CT scan of the heart (Intervention Group B) and who were found to have a calcium score of 300 or higher will be mailed an invitation for ROBINSCA-MR. In the first instance, a small part of the potential participants will receive an invitation letter with information. This number will gradually be expanded. All ROBINSCA participants in intervention group B and a calcium score of 300 or higher will eventually receive an invitation letter.

The researchers from the Erasmus MC and the UMCG are very pleased that ROBINSCA-MR has started and hope to gather valuable information about the development of serious cardiovascular diseases, such as a heart attack, with the help of all the participants. RADventure is proud to deliver the needed workflow software and to provide the secure hosting environment for this study. Click for more background information (in Dutch) on the following link: ROBINSCA-MR started.

ROBINSCA-MR
2015

The RADventure Group earned the ISO Certification 9001:2015!

In 2017, RADventure implemented this quality certification according to the new norm DIN EN ISO 9001:2015. After a successful recertification audit end 2017, TÜV Rheinland issued the new certificate, which is valid until February 2021. The high quality standard and integrated IT-systems for customer-related processes are the main pillars for this success.

 

The new ISO 9001 considers not only our valuable customers, but also other “interested parties”. Those have been analyzed and assessed by RADventure. Topics such as risk management, change management and knowledge management also play a vital role. The new norm maintains the process-oriented approach and requires “risk-based thinking”. RADventure considered these topics and has included respective measures into its processes. By being certified pursuant to the ISO9001:2015, RADventure will assure quality in accordance with valid international standards which is a major step for us, our customers and the company’s future.

9108623645_767506
MDL

MDL TRANS.IT

The Business Intelligence environment created for Trans.IT is a big success. In the most recent publication of MAGMA (Magazine of the Dutch Association of Gastroenterologists) an article is written about this BI-system: https://lnkd.in/gU-PrSV

news-radventure-website

New Website Launch

We are happy to announce the launch of our new RADventure Group Website!
The website has been redesigned to improve user friendliness and appearance.
We hope you will enjoy our new site.
For any questions, suggestions, feedback or comments, please get in touch using our contact form.

 

With regards,
The RADventure Group team

canary-island

Canary Islands

For several years RADventure provides the Management Information System (called BCS) for the breast cancer screening implementation on the Canary Islands. We are very pleased to announce that the Canary Islands Government awarded the continuation of the support for this system. We look forward to continue our support for the breast cancer screening in the Canary Islands.

trans.it

Trans.IT launched the Central Data warehouse

In January 2017 Trans.IT launched the Central Data warehouse for Gastroenterologist departments for multiple hospitals. Within each hospital all exams are recorded in a reporting database. Once per day a specific dataset is (anonymously) send from this reporting system to the Trans.IT central data warehouse. Each Gastroenterologist is able to use this central Data warehouse using a business intelligence tool to manage the department and analyze the data.

For more details see the project: Trans.IT

And more info here: http://www.trans-it.org/

news-ecr-vienna

ECR VIENNA

RADventure attended the 2016 ECR conference at Vienna. We appreciate the quality of sessions we were able to join. Several speakers talked about the future of cancer screening, and they all had one topic in common: Personalized Screening. It was nice to see that our screening software solutions already anticipate and support these new developments. We had the opportunity to show our screening solutions to interested organizations / delegations. ECR 2016: a great way to learn and share information about radiology solutions in healthcare. RADventure was glad to be a part of this!

news-development-robinsca

RADventure supports the ROBINSCA project

Cardiovascular diseases are the primary cause of morbidity and mortality in Europe. Early detection (screening) and treatment for cardiovascular diseases in large groups of people without symptoms (general population) might have the opportunity to reduce cardiovascular-related morbidity and mortality. However, evidence is lacking whether the benefits of screening (e.g. reduced morbidity and mortality) justify the potential harms (e.g. unnecessary treatment, costs).

The ROBINSCA (Risk Or Benefit IN Screening for Cardiovascular disease) is the only large-scale population-based randomized controlled trial that investigates the cost-effectiveness of screening for cardiovascular diseases. About 39,000 participants will be randomized to either the control arm (no screening), intervention arm A (risk calculation by means of well-known risk factors) or intervention group B (risk calculation by means of coronary artery calcium scoring (CT scan)). After five years, these groups will be compared regarding differences in cardiovascular-related morbidity and mortality.

Based on over 15 years of experience with preventative cancer screening projects, RADventure has built the software to manage the logistic flow of this research program. The ROBINSCA-system connects to the population registry in The Netherlands to obtain and synchronize data. It manages the status of almost 400,000 initial individuals through invitations and risk assessments, study enrollment, randomization, planning, invitation management and the data collection from laboratories and scan centers. It provides extensive functionality to conduct complex sample investigations related to individual milestones and provides multiple modalities to communicate with participants. The system provides intuitive two-way interfaces for anonymized statistical processing.

Beginning of March 2015, the first 5,196 participants were randomized and enrolled in the study.

The RADventure Group is specializing in supporting and managing preventative screening programs and established several ICT systems for both national and international screening programs since the year 2000.

Contact Info

Computerweg 3

3542 DP Utrecht

The Netherlands

(+31) (0)88 77 647 47
info@RADventure.com

Daily: 8.30AM to 5.30PM CET

Copyright RADventure 2020 © All Rights Reserved